A key debate for how bonds fare in the weeks and months ahead is linked to expectations for the US economy.
It is an excellent time to reassess portfolio risk exposures. Shifting toward more defensive assets could be prudent. Capital preservation should be the priority in times of uncertainty.
By Sheraz Mian
Total S&P 500 earnings are currently expected to be up +3.9% from the same period last year on +4.6% higher revenues.
Cryptocurrency Celestia with ticker TIAUSD forms a nice bullish setup with impulsive five-wave rally, followed by an A-B-C corrective setback that can send the price higher by Elliott wave theory.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Over the past year, Pfizer's share price fell about 12.7% from $34.07 to $29.75 as of Wednesday’s market close.
CPI data shows a decline in inflation, leading to expectations of a Fed rate cut.
Hypera SA (HYPMY) is a specialty and generic drug manufacturing company. Over the past year, Hypera share price fell about 31% from $7.67 to $5.30 as of Tuesday’s market close.